The short term investing stock picks blog

Sell price: $54.67 or
Sell date: March 16, 2007
Stop loss: $49.77 (-4.4%)

EMA/MACD very bullish
Fibonacci analysis bullish
Strong bullish 3 day chart pattern with Strong 3 day accumulation.
Extreme bullish 1 day moneyflow

Profile: Gen-Probe Incorporated (Gen-Probe) is engaged in developing, manufacturing and marketing nucleic acid probe-based products used for the clinical diagnosis of human diseases and screening donated human blood. The Company also develops and manufactures nucleic acid probe-based products for the detection of harmful organisms in the environment and in industrial processes. Gen-Probe’s principal customers are large reference laboratories, public health laboratories and hospitals located in North America, Europe and Japan. The Company’s products are categorized into clinical diagnostic products and blood-screening products. Clinical diagnostic products are for the detection of viral and non-viral microorganisms. Blood-screening products is developed for assays. In May 2005, the Company acquired the remaining outstanding shares of Molecular Light Technology Limited (MLT), giving the Company 100% ownership.